Eloxx Pharmaceuticals (ELOX) Share-based Compensation (2010 - 2026)
Eloxx Pharmaceuticals' Share-based Compensation was $95,000 in Q2 2026, up 493.8% from $16,000 a year earlier and up 106.5% from the prior quarter.
Powered by 
Analysis
Eloxx Pharmaceuticals (ELOX) Share-based Compensation (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Eloxx Pharmaceuticals' Share-based Compensation was $177,000 through Jun 30, 2026, down 77.7% year-over-year; for FY2025, it came in at $235,000, down 56.6% from FY2024.
- Share-based Compensation has now declined for four consecutive years, with a five-year compound annual growth rate of -51.4% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $541,000 in FY2024 (-72.5%), $1.97 million in FY2023 (-35.0%), $3.02 million in FY2022 (-67.0%) and $9.17 million in FY2021 (+5.8%).
- The Q2 2026 figure marks the highest quarterly Share-based Compensation since Q4 2023.
- The best year-over-year quarter for Share-based Compensation over five years was Q2 2026 (growth of 493.8%); the worst was Q2 2022 (a decline of 81.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.23 Bn | 1,138.82 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 648.85 Bn | 568.71 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 504.91 Bn | 478.02 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 368.25 Bn | 322.63 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 303.41 Bn | 267.40 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 268.65 Bn | 242.33 Bn | 12.86 Bn | - |
| 7 | Amgen | 242.96 Bn | 198.36 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 195.01 Bn | 169.21 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 173.22 Bn | 119.87 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Eloxx Pharmaceuticals | 85.82 Mn | 12.14 Mn | - | 95,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 95,000.00 |
| Mar 31, 2026 | 46,000.00 |
| Jun 30, 2025 | 16,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2023 | 340,000.00 |
| Sep 30, 2023 | 418,000.00 |
| Jun 30, 2023 | 610.00 |
| Mar 31, 2023 | 597,000.00 |
| Dec 31, 2022 | 641,000.00 |
| Sep 30, 2022 | 714,000.00 |
| Jun 30, 2022 | 744.00 |
| Mar 31, 2022 | 922,000.00 |
| Dec 31, 2021 | 1.60 Mn |
| Sep 30, 2021 | 2.22 Mn |
| Jun 30, 2021 | 4.04 Mn |
| Mar 31, 2021 | 1.31 Mn |
| Dec 31, 2020 | 1.28 Mn |
| Sep 30, 2020 | 1.41 Mn |
| Jun 30, 2020 | 1.98 Mn |
| Mar 31, 2020 | 4.00 Mn |
API Access
Eloxx Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ELOX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ELOX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ELOX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();